Pharmacological studies on tiadenol in type IV patients Evidence for a mechanism of action different from other lipid-lowering drugs
- 1 November 1981
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 40 (3-4) , 245-255
- https://doi.org/10.1016/0021-9150(81)90134-9
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Clofibrate, pirinixil (BR 931) and WY-14,643 do not affect body cholesterol in Sprague-Dawley ratsAtherosclerosis, 1980
- The concentration of high density lipoprotein in patients with type IV hyperlipoproteinemia and the effect of clofibrateAtherosclerosis, 1980
- The influence of clofibrate on lipid and protein components of very low density lipoproteins in type IV hyperlipoproteinaemiaAtherosclerosis, 1980
- Relative increase in apolipoprotein CII content of VLDL and chylomicrons in a case with massive type V hyperlipoproteinaemia by nicotinic acid treatmentAtherosclerosis, 1978
- Intestinal apoproteins during fat absorption.Journal of Clinical Investigation, 1978
- The effect of treatment with clofibrate on hepatic triglyceride and lipoprotein lipase activities of post heparin plasma in male patients with hyperlipoproteinemiaAtherosclerosis, 1977
- On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemia in type IV and type V hyperlipoproteinaemiasAtherosclerosis, 1977
- Metformin: An antiatherosclerotic agent modifying very low density lipoproteins in rabbitsAtherosclerosis, 1977
- Apoprotein composition of very low density lipoproteins of human serum.Journal of Clinical Investigation, 1975
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955